BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 17.07.2024

Platform Technology Designation Program; Draft Guidance for Industry; Extension of Comment Period

The Food and Drug Administration (FDA or the Agency) is extending the comment period for the draft guidance for industry "Platform Technology Designation Program for Drug Development" that appeared in the Federal Register of May 29, 2024. In the notice of availability for the draft guidance, FDA requested comments on the proposed collection of information. The Agency is taking this action in response to requests for an extension to allow interested persons additional time to submit comments.

Source: Federal Register — Food and Drug AdministrationOpen original release →